EFFICACY OF PATHOGENETIC THERAPY FOR ATOPIC DERMATITIS IN INFANTS
Abstract
The article looks at the issue of atopic dermatitis as a manifestation of atopic march in infants. Authors provide results of their own observations in the use of modern topical steroid — mometasone furoate — in the integrated therapy. This glucocorticosteroid does not contain fluorine and has predominantly non-genomic mechanism. The results of the study evidenced a high efficacy and good tolerance to this topical steroid.
Key words: atopic dermatitis, children, momethasone furoate.
(Pediatric Pharmacology. – 2010; 7(2):87-90)
About the Authors
T.G. MalanichevaRussian Federation
L.A. Khaertdinova
Russian Federation
Review
For citations:
Malanicheva T., Khaertdinova L. EFFICACY OF PATHOGENETIC THERAPY FOR ATOPIC DERMATITIS IN INFANTS. Pediatric pharmacology. 2010;7(2):87-90.
Email this article 